CEO David Muller Says Allotex Looks to Create Living Contact Lens with Corneal Allograft

AGTC's Washer on Joining BIO Board

Episode 176

Last time we talked with David Muller, PhD, he was leaving Avedro to start a new company. Two years later, Dr. Muller’s company, Allotex, has raised capital from a strategic investor and is preparing to enter clinical trials in Europe. In this OIS Podcast, Muller tells us why Allotex may succeed where others have fallen short. For more on Allotex, watch this Companies to Watch presentation.

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Meet Our Host

TOM SALEMI

Tom-Salemi

Joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.